Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 6 EP applications Susan Ann Chiappinelli has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12702009

NOVEL ANTIGEN BINDING PROTEINS

IPC classification:
C07K 16/22
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12749198

METHODS OF IDENTIFYING A PATIENT POPULATION

IPC classification:
A61K 38/17
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12735498

THERAPEUTIC COMBINATIONS OF ANTI -CD20 AND ANTI - GM - CSF ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/24
Applicant:
MorphoSys AG
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13784908

NOVEL ANTIBODIES

IPC classification:
A61K 39/395
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13732986

OPTIMUM DOSE REGIME OF AN ANTI-NOGO-A ANTIBODY IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

IPC classification:
C07K 16/22
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11743554

IMPROVED ANTI-SERUM ALBUMIN BINDING VARIANTS

IPC classification:
C12N 15/13, C07K 16/18
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Susan Ann Chiappinelli, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature